Terms: = Lymphoma AND DCTN1, DAP-150, 1639, ENSG00000204843, Q14203, P135, DP-150 AND Treatment
16 results:
1. Multisystem ALK-positive histiocytosis: a multi-case study and literature review.
Liu W; Liu HJ; Wang WY; Tang Y; Zhao S; Zhang WY; Yan JQ; Liu WP
Orphanet J Rare Dis; 2023 Mar; 18(1):53. PubMed ID: 36915094
[TBL] [Abstract] [Full Text] [Related]
2. PAX5 epigenetically orchestrates CD58 transcription and modulates blinatumomab response in acute lymphoblastic leukemia.
Li Y; Moriyama T; Yoshimura S; Zhao X; Li Z; Yang X; Paietta E; Litzow MR; Konopleva M; Yu J; Inaba H; Ribeiro RC; Pui CH; Yang JJ
Sci Adv; 2022 Dec; 8(50):eadd6403. PubMed ID: 36516256
[TBL] [Abstract] [Full Text] [Related]
3. ALK-rearranged Mesenchymal Neoplasms: A Report of 9 cases Further Expanding the Clinicopathologic Spectrum of Emerging Kinase Fusion Positive Group of Tumors.
Dermawan JK; DiNapoli SE; Mullaney KA; Sukhadia P; Agaram NP; Dickson BC; Antonescu CR
Genes Chromosomes Cancer; 2023 Feb; 62(2):75-84. PubMed ID: 36125853
[TBL] [Abstract] [Full Text] [Related]
4. Effectiveness of alectinib and osimertinib in a brain metastasized lung adenocarcinoma patient with concurrent EGFR mutations and dctn1-ALK fusion.
Yin Q; Guo T; Zhou Y; Sun L; Meng M; Ma L; Wang X
Thorac Cancer; 2022 Feb; 13(4):637-642. PubMed ID: 34964276
[TBL] [Abstract] [Full Text] [Related]
5. dctn1-ALK gene fusion in inflammatory myofibroblastic tumor (IMT) of the CNS.
Vidrine DW; Berry JF; Garbuzov A; Falcon C; Tubbs RS; Bui CJ
Childs Nerv Syst; 2021 Jul; 37(7):2147-2151. PubMed ID: 34014367
[TBL] [Abstract] [Full Text] [Related]
6. Elevated Cardiovascular Disease Risk in Patients With Chronic Myelogenous Leukemia Seen in Community-based Oncology Practices in the United States.
Coutinho AD; Makenbaeva D; Farrelly E; Landsman-Blumberg PB; Lenihan D
Clin Lymphoma Myeloma Leuk; 2017 Oct; 17(10):676-683. PubMed ID: 28729178
[TBL] [Abstract] [Full Text] [Related]
7. Philadelphia-Like Acute Lymphoblastic Leukemia in Adults.
Herold T; Gökbuget N
Curr Oncol Rep; 2017 May; 19(5):31. PubMed ID: 28361222
[TBL] [Abstract] [Full Text] [Related]
8. Temporal Trends in treatment and Subsequent Neoplasm Risk Among 5-Year Survivors of Childhood Cancer, 1970-2015.
Turcotte LM; Liu Q; Yasui Y; Arnold MA; Hammond S; Howell RM; Smith SA; Weathers RE; Henderson TO; Gibson TM; Leisenring W; Armstrong GT; Robison LL; Neglia JP
JAMA; 2017 Feb; 317(8):814-824. PubMed ID: 28245323
[TBL] [Abstract] [Full Text] [Related]
9. [A Retrospective Study of Ph Negative Adolescent and Young Adults with Acute B Lymphoblastic Leukemia in Two Centers].
Gao HH; Jing Y; Liu MJ; Li HH; Huang WR; Gao CJ; Liu DH; Li YH; Huang S; Li Y; Liu J; Zhang YQ; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Dec; 24(6):1683-1690. PubMed ID: 28024477
[TBL] [Abstract] [Full Text] [Related]
10. Risk-Benefit Analysis of Pediatric-Inspired Versus Hyperfractionated Cyclophosphamide, Vincristine, Doxorubicin, and Dexamethasone Protocols for Acute Lymphoblastic Leukemia in Adolescents and Young Adults.
Guzauskas GF; Villa KF; Vanhove GF; Fisher VL; Veenstra DL
J Adolesc Young Adult Oncol; 2017 Mar; 6(1):53-61. PubMed ID: 27779442
[TBL] [Abstract] [Full Text] [Related]
11. STUMP un"stumped": anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid features harboring dctn1-ALK fusion.
Subbiah V; McMahon C; Patel S; Zinner R; Silva EG; Elvin JA; Subbiah IM; Ohaji C; Ganeshan DM; Anand D; Levenback CF; Berry J; Brennan T; Chmielecki J; Chalmers ZR; Mayfield J; Miller VA; Stephens PJ; Ross JS; Ali SM
J Hematol Oncol; 2015 Jun; 8():66. PubMed ID: 26062823
[TBL] [Abstract] [Full Text] [Related]
12. Malignant hematologic diseases in adolescents and young adults.
Wood WA; Lee SJ
Blood; 2011 Jun; 117(22):5803-15. PubMed ID: 21398581
[TBL] [Abstract] [Full Text] [Related]
13. Survival in young patients (less than 40 years) with follicular lymphoma: a population based study by the Scotland and Newcastle lymphoma Group.
Summerfield GP; Wood KM; Taylor PR; White JM; Mounter PJ; Proctor SJ
Leuk Lymphoma; 2004 Jun; 45(6):1149-57. PubMed ID: 15359994
[TBL] [Abstract] [Full Text] [Related]
14. Outcome of residual mediastinal masses of thoracic lymphomas in children: impact on management and radiological follow-up strategy.
Brisse H; Pacquement H; Burdairon E; Plancher C; Neuenschwander S
Pediatr Radiol; 1998 Jun; 28(6):444-50. PubMed ID: 9634459
[TBL] [Abstract] [Full Text] [Related]
15. Avascular necrosis of bone after adult acute lymphocytic leukemia treatment with methotrexate, vincristine, L-asparaginase, and dexamethasone (MOAD).
Hui L; Wiernik PH
Am J Hematol; 1996 Jul; 52(3):184-8. PubMed ID: 8756084
[TBL] [Abstract] [Full Text] [Related]
16. Multiple primary cancer risk after therapy for Hodgkin's disease.
Brody RS; Schottenfeld D; Reid A
Cancer; 1977 Oct; 40(4 Suppl):1917-26. PubMed ID: 907994
[TBL] [Abstract] [Full Text] [Related]
